Assessing Role of Comorbidities in Treatment Selection for Older Patients with Acute Myeloid Leukemia
Justin Grenet(Cornell University), Pinkal Desai(NewYork–Presbyterian Hospital), Gail J. Roboz(Cornell University), Xiaoyue Ma(Xi'an Jiaotong University), Paul J. Christos(Cornell University), Akriti Jain(Cleveland Clinic), Jonathan Canaani(NewYork–Presbyterian Hospital), Neela Easwar(University of California San Diego), Kendra Sweet(Moffitt Cancer Center), Aaron D. Goldberg(Memorial Sloan Kettering Cancer Center), Shira Dinner(Dana-Farber Cancer Institute), Justin D. Kaner(NewYork–Presbyterian Hospital), Ellen K. Ritchie(Cornell University), Michael S. Samuel(Cancer Research UK Scotland Institute), Madelyn Burkart(Atrium Health Wake Forest Baptist)
Cited by 1
Related Papers
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k